ConductScience.org, home

Paper38839628

The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.

Jin S and 5 others. Inflamm Res, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review. Papers, record 38839628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38839628

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.
PubMed
Journal
Inflamm Res
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.61, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jin SShiyu
2Wan SSheng
3Xiong RRenxue
4Li YYujie
5Dong TTingru
6Guan CCuiping

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
VitiligoMajor topic
Humans
Animals
Autoantigens
Receptors, Chemokine
Signal Transduction
Drug Discovery

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. LY21H110001Zhejiang Provincial Natural Science Foundation of ChinaPubMed
No. 2021KY903Zhejiang medical and health science and technology projectPubMed
No. [2021]21-3Hangzhou medical key discipline construction projectPubMed

Source PubMed

Download CSV of grants

References217

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132425260Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.Semin Arthritis Rheum2020https://conductscience.org/library/papers/32425260PubMed
219303254MicroRNA in autoimmunity and autoimmune diseases.J Autoimmun2009https://conductscience.org/library/papers/19303254PubMed
325977193Wnt signaling in dendritic cells: its role in regulation of immunity and tolerance.Discov Med2015https://conductscience.org/library/papers/25977193PubMed
427186967Interleukin 10 protects primary melanocyte by activation of Stat-3 and PI3K/Akt/NF-κB signaling pathways.Cytokine2016https://conductscience.org/library/papers/27186967PubMed
524935676Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.Pigment Cell Melanoma Res2014https://conductscience.org/library/papers/24935676PubMed
627862977Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia.Cytometry B Clin Cytom2018https://conductscience.org/library/papers/27862977PubMed
719242513Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients.J Invest Dermatol2009https://conductscience.org/library/papers/19242513PubMed
811511311
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.
J Invest Dermatol2001https://conductscience.org/library/papers/11511311PubMed
924058794Interleukin-2 and STAT5 in regulatory T cell development and function.JAKSTAT2013https://conductscience.org/library/papers/24058794PubMed
1020952687Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.Blood2011https://conductscience.org/library/papers/20952687PubMed
1133284575Steroid-Peptide Immunoconjugates for Attenuating T Cell Responses in an Experimental Autoimmune Encephalomyelitis Murine Model of Multiple Sclerosis.Bioconjug Chem2020https://conductscience.org/library/papers/33284575PubMed
1222566933Molecular mechanisms of treg-mediated T cell suppression.Front Immunol2012https://conductscience.org/library/papers/22566933PubMed
1323498308Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India.J Am Acad Dermatol2013https://conductscience.org/library/papers/23498308PubMed
1420175879Reduced skin homing by functional Treg in vitiligo.Pigment Cell Melanoma Res2010https://conductscience.org/library/papers/20175879PubMed
1527192518Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review.An Bras Dermatol2016https://conductscience.org/library/papers/27192518PubMed
1618509048T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18509048PubMed
1737312906Evaluation of polymorphisms and expression of PTPN22, NLRP1 and TYR genes in vitiligo patients.Postepy Dermatol Alergol2023https://conductscience.org/library/papers/37312906PubMed
1818725526Dicer-dependent microRNA pathway safeguards regulatory T cell function.J Exp Med2008https://conductscience.org/library/papers/18725526PubMed
1936183915Preclinical evaluation of a microparticle-based transdermal vaccine patch against metastatic breast cancer.Int J Pharm2022https://conductscience.org/library/papers/36183915PubMed
2035008594COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis.Int J Mol Sci2021https://conductscience.org/library/papers/35008594PubMed

See all 217 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42823602Rezpegaldesleukin and Regulatory T Cell Restoration in Immune-Mediated Skin Diseases.Dermatol Ther (Heidelb)2026https://conductscience.org/library/papers/42823602PubMed
42633438From Mechanisms to Clinical Practice: Advances in Vitiligo Treatment Across Western Medicine and Traditional Chinese Medicine.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/42633438PubMed
42233009Regulatory T cells in vitiligo: a review of functional disequilibrium between peripheral blood and lesional tissue.Front Immunol2026https://conductscience.org/library/papers/42233009PubMed
42183190Regulatory T cell therapy in autoimmune and immune-mediated diseases: from basic research to clinical practice and future perspectives.Front Immunol2026https://conductscience.org/library/papers/42183190PubMed
41035845recent advances in the pathogenesis of vitiligo and the application of novel drug delivery systems in its treatment.Int J Pharm X2025https://conductscience.org/library/papers/41035845PubMed
40703229Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis.Front Microbiol2025https://conductscience.org/library/papers/40703229PubMed
40114929The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis.Front Immunol2025https://conductscience.org/library/papers/40114929PubMed
39967732Identification of disease-specific gut microbial markers in vitiligo.Front Microbiol2025https://conductscience.org/library/papers/39967732PubMed
39125670Exploring New Frontiers: Innovations and Therapeutic Targets in Dermatology.Int J Mol Sci2024https://conductscience.org/library/papers/39125670PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38839628

GET https://conductscience.org/api/papers/v1/38839628/references?page=2